Clinical Edge Journal Scan

Patients with chronic rhinosinusitis are at risk for subsequent atopic dermatitis


 

Key clinical point: Patients with chronic rhinosinusitis (CRS) were more likely to develop atopic dermatitis (AD), particularly young (<45 years) and middle-aged (45-64 years) patients.

Major finding: The risk of developing AD was significantly higher in patients with vs. without CRS (adjusted hazard ratio [aHR] 1.1952; 95% CI 1.1009-1.2976), especially among young (aHR 1.1491; 95% CI 1.0386-1.2713) and middle-aged (aHR 1.2944; 95% CI 1.1044-1.5171) patients.

Study details: This was a longitudinal cohort study that included 16,668 patients with CRS and 33,336 sociodemographically matched control individuals without CRS who were followed-up for 11 years.

Disclosures: This research was supported by Hallym University Research Fund and the National Research Foundation funded by the Korean government. The authors declared no conflicts of interest.

Source: Son D-S et al. Chronic rhinosinusitis and the increased incidence of atopic dermatitis. Am J Rhinol Allergy. 2022 (Mar 29). Doi: 10.1177/19458924221090050

Recommended Reading

Meta-analysis concurs occurrence of lower serum 25(OH)D levels in atopic dermatitis
MDedge Dermatology
Global registry tracks COVID-19 outcomes in atopic dermatitis patients
MDedge Dermatology
Clinical Edge Journal Scan Commentary: Atopic Dermatitis April 2022
MDedge Dermatology
Review of Ethnoracial Representation in Clinical Trials (Phases 1 Through 4) of Atopic Dermatitis Therapies
MDedge Dermatology
Probiotic LGG doesn’t lessen eczema, asthma, or rhinitis risk by age 7
MDedge Dermatology
Cupping in dermatology
MDedge Dermatology
Meta-analysis presents relative effect estimates for systemic immunomodulatory treatments for atopic dermatitis
MDedge Dermatology
Effect of dupilumab on SARS-CoV-2 antibody response in atopic dermatitis
MDedge Dermatology
Meta-analysis evaluates efficacy and safety of oral and topical JAKi in atopic dermatitis
MDedge Dermatology
BNT162b2 SARS-CoV-2 vaccination highly recommended for patients with atopic dermatitis
MDedge Dermatology